We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Clinical Updates

Clinical Updates

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Predictive Power of MRI-Based Radiomic Dynamics for Pathological Complete Response in Hepatocellular Carcinoma: A Deep Learning Synthesis
Clinical Updatesdeep learninghepatocellular carcinoma

Predictive Power of MRI-Based Radiomic Dynamics for Pathological Complete Response in Hepatocellular Carcinoma: A Deep Learning Synthesis

By MedXY|Mar 15, 2026

This review evaluates how deep learning-assisted delta radiomics on MRI, combined with AFP response, provides a non-invasive, high-accuracy prediction of pathological complete response in unresectable HCC undergoing conversion immunotherapy

Therapeutic Reversal of SOX9-Mediated Chemoresistance in Esophageal Adenocarcinoma via APE1-Redox Inhibition
Clinical UpdatesAPE1Chemoresistance

Therapeutic Reversal of SOX9-Mediated Chemoresistance in Esophageal Adenocarcinoma via APE1-Redox Inhibition

By MedXY|Mar 15, 2026

This review details a breakthrough in esophageal adenocarcinoma treatment, identifying the APE1-SOX9 axis as a primary driver of chemoresistance and demonstrating how targeting APE1’s redox function can sensitize tumors to oxaliplatin

Disentangling Cognitive Decline: The Interplay of White Matter Hyperintensities and Cortical Metabolism in Amyloid-Negative Patients
Clinical Updatescognitive impairmentglucose metabolism

Disentangling Cognitive Decline: The Interplay of White Matter Hyperintensities and Cortical Metabolism in Amyloid-Negative Patients

By MedXY|Mar 15, 2026

This review synthesizes findings on how periventricular white matter hyperintensities (PWMHs) drive cognitive impairment in Aβ-negative individuals through distinct metabolic mediation and direct structural pathways, highlighting the clinic

Interaction Between SGLT2 Inhibition and Dietary Sodium: Insights from the CREDENCE Trial Post Hoc Analysis
CardiologyCanagliflozinchronic kidney disease

Interaction Between SGLT2 Inhibition and Dietary Sodium: Insights from the CREDENCE Trial Post Hoc Analysis

By MedXY|Mar 15, 2026

This post hoc analysis of the CREDENCE trial reveals that low-normal sodium intake increases cardiovascular risk in T2D and CKD, a risk significantly mitigated by canagliflozin, while renal protection remains consistent across sodium intake

The Changing Landscape of Mortality in Diabetes: A Shift from Cardiovascular Dominance to Cancer and Dementia
CardiologycancerCardiovascular Mortality

The Changing Landscape of Mortality in Diabetes: A Shift from Cardiovascular Dominance to Cancer and Dementia

By MedXY|Mar 15, 2026

This review analyzes multinational data showing a significant decline in cardiovascular mortality among diabetes patients, alongside a concerning rise in dementia-related deaths and the emergence of cancer as a leading cause of mortality in

Residual Clinical Risk and Economic Burden in HFrEF: Insights from the Quadruple Medical Therapy Era
CardiologyGDMTHFrEF

Residual Clinical Risk and Economic Burden in HFrEF: Insights from the Quadruple Medical Therapy Era

By MedXY|Mar 15, 2026

This review analyzes the real-world one-year outcomes and healthcare costs for HFrEF patients on quadruple therapy, revealing significant residual risk despite optimized pharmacologic management.

Adipocyte-Cardiomyocyte Communication via Surface-Bound Adiponectin: Mechanisms of sEV Failure in Diabetic Ischemic Heart Failure
CardiologyAdiponectinAdipoR1

Adipocyte-Cardiomyocyte Communication via Surface-Bound Adiponectin: Mechanisms of sEV Failure in Diabetic Ischemic Heart Failure

By MedXY|Mar 15, 2026

This review explores how adipocyte-derived small extracellular vesicles (sEVs) use surface-bound adiponectin to protect the heart, and how diabetes-induced GRK2 upregulation disrupts this vital signaling pathway, leading to ischemic heart f

Malignancy Risk Patterns in Solid Organ Transplant Recipients with a History of Pretransplant Cancer
Clinical Updatesimmunosuppressiononcology

Malignancy Risk Patterns in Solid Organ Transplant Recipients with a History of Pretransplant Cancer

By MedXY|Mar 15, 2026

A large-scale cohort study reveals that solid organ transplant recipients with pre-existing cancer histories face significantly elevated risks for subsequent malignancies, particularly recurring or de novo cancers of the same type, necessit

SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes: A Comparative Effectiveness Review
Clinical Updateschronic kidney diseaseGLP-1RA

SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes: A Comparative Effectiveness Review

By MedXY|Mar 15, 2026

This review synthesizes evidence comparing SGLT2 inhibitors and GLP-1 receptor agonists, highlighting a significant reduction in chronic kidney disease and acute kidney injury risks associated with SGLT2i initiation.

Standardizing Outcomes Research: A Robust Extraction Pipeline for Hematopoietic Stem Cell Transplantation Registry Data
Clinical UpdatesData ScienceHSCT

Standardizing Outcomes Research: A Robust Extraction Pipeline for Hematopoietic Stem Cell Transplantation Registry Data

By MedXY|Mar 15, 2026

This review evaluates a novel open-source extraction pipeline designed to standardize and automate the processing of complex HSCT registry data, enhancing reproducibility and precision in clinical outcomes research.

Mapping the Preclinical Phase: The Conserved Sequence of Lung Function Decline in Idiopathic Pulmonary Fibrosis
Clinical UpdatesDisease ProgressionDLCO

Mapping the Preclinical Phase: The Conserved Sequence of Lung Function Decline in Idiopathic Pulmonary Fibrosis

By MedXY|Mar 13, 2026

A landmark study identifies a decade-long conserved sequence of disease progression in IPF, revealing that DLCO decline precedes FVC impairment by years, providing a new framework for early diagnosis and clinical trial design.

Beyond the Cornea: Evaluating the Systemic Cardiometabolic Burden in Fuchs’ Endothelial Corneal Dystrophy
Clinical UpdatesFECDmetabolic syndrome

Beyond the Cornea: Evaluating the Systemic Cardiometabolic Burden in Fuchs’ Endothelial Corneal Dystrophy

By MedXY|Mar 13, 2026

Recent data from the NIH All of Us Research Program indicates that Fuchs’ Endothelial Corneal Dystrophy (FECD) is associated with a significantly higher prevalence of cardiometabolic comorbidities, suggesting a systemic component to t

Beyond the Bloat: Addressing the Neuropsychiatric Burden of Retrograde Cricopharyngeus Dysfunction through Targeted Botulinum Toxin Intervention
Clinical Updatesanxietydepression

Beyond the Bloat: Addressing the Neuropsychiatric Burden of Retrograde Cricopharyngeus Dysfunction through Targeted Botulinum Toxin Intervention

By MedXY|Mar 13, 2026

This review analyzes the high prevalence of anxiety and depression in patients with Retrograde Cricopharyngeus Dysfunction (RCPD) and evaluates the significant, sustained mental health improvements following cricopharyngeal botulinum toxin

Tamoxifen and Uterine Disease Risk in Young Breast Cancer Survivors: Evidence from a Target Trial Emulation Study
Clinical Updatesbreast cancerEndometrial Cancer

Tamoxifen and Uterine Disease Risk in Young Breast Cancer Survivors: Evidence from a Target Trial Emulation Study

By MedXY|Mar 13, 2026

A large-scale cohort study of premenopausal women demonstrates that adjuvant tamoxifen significantly increases the risk of endometrial cancer, hyperplasia, and polyps, with risk correlating to treatment duration.

Exoskeleton-Assisted Therapy for Upper Limb Motor Recovery in Early Subacute Stroke: Evidence from a Multicenter Randomized Controlled Trial
Clinical UpdatesExoskeletonneuroplasticity

Exoskeleton-Assisted Therapy for Upper Limb Motor Recovery in Early Subacute Stroke: Evidence from a Multicenter Randomized Controlled Trial

By MedXY|Mar 13, 2026

A comprehensive review of a multicenter RCT (Morone et al., 2026) demonstrating that exoskeleton-based robot-assisted therapy significantly improves upper limb motor impairment and clinical outcomes in the early subacute phase of stroke rec

Predictive Biomarkers in PML: Preexisting Virus-Specific T Cells as Determinants of Response to Checkpoint Inhibition
Clinical UpdatesCheckpoint InhibitorsT細胞免疫学

Predictive Biomarkers in PML: Preexisting Virus-Specific T Cells as Determinants of Response to Checkpoint Inhibition

By MedXY|Mar 13, 2026

This review synthesizes recent evidence on the role of pretreatment virus-specific T cells in predicting clinical response, survival, and safety outcomes in patients with progressive multifocal leukoencephalopathy (PML) treated with immune

Uncoupling Metabolic Benefit from Glycemic Control: Empagliflozin’s Superiority Over Insulin in Beta Cell Preservation
Clinical UpdatesBeta-cell functioninsulin sensitivity

Uncoupling Metabolic Benefit from Glycemic Control: Empagliflozin’s Superiority Over Insulin in Beta Cell Preservation

By MedXY|Mar 13, 2026

A randomized cross-over trial reveals that empagliflozin enhances beta cell function and insulin sensitivity more effectively than titrated insulin, suggesting benefits beyond simple glucotoxicity relief.

Lifestyle Determinants and Metabolic Compensation in Pregnancies Complicated by Type 1 Diabetes: A Synthesis of the ENDIA Study and Recent Evidence
Clinical UpdatesIslet Autoimmunitynutrition

Lifestyle Determinants and Metabolic Compensation in Pregnancies Complicated by Type 1 Diabetes: A Synthesis of the ENDIA Study and Recent Evidence

By MedXY|Mar 13, 2026

This review analyzes the lifestyle patterns of pregnant women with type 1 diabetes, synthesizing findings from the ENDIA study with recent evidence on nutritional adequacy, islet autoimmunity, and the molecular mechanisms of metabolic compe

Optimizing Prehospital Pathways: Impact of the Iranian Comprehensive Code Stroke Management Program (ICSM Phase III) on Thrombolysis Rates
Clinical UpdatesalteplaseEmergency Medical Services

Optimizing Prehospital Pathways: Impact of the Iranian Comprehensive Code Stroke Management Program (ICSM Phase III) on Thrombolysis Rates

By MedXY|Mar 11, 2026

This review analyzes the ICSM Phase III study, highlighting how a structured empowerment program and standardized protocols in EMS significantly reduced prehospital delays and tripled alteplase administration rates for acute ischemic stroke

Long-Term Thyroid Toxicity Burden in Children Who Received Treatment for High-Risk Neuroblastoma
Clinical UpdatesĐộc tính tuyến giápneuroblastoma

Long-Term Thyroid Toxicity Burden in Children Who Received Treatment for High-Risk Neuroblastoma

By MedXY|Mar 11, 2026

This review analyzes the significant long-term thyroid toxicity burden in high-risk neuroblastoma survivors, identifying key risk factors such as molecular radiotherapy, tandem myeloablative therapy, and immunotherapy.

Prev
18 / 25
1…1617181920…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles